Loading organizations...
BlackMars Capital is a German investment firm providing capital to fast-growing technology companies. It strategically focuses on industries ripe for disruptive change, encompassing Artificial Intelligence, Blockchain, High Performance Computing, Life Sciences, Quantum Computing, and Robotics. The firm partners with early-stage teams, embracing intrinsic risks to develop enduring businesses.
Co-founded in 2012 by Marco Beckmann, its Managing Director, BlackMars Capital emerged from Beckmann’s 15-year investment experience and insight to fund disruptive technological ideas. The firm’s structure allows it to absorb risks of early-stage companies, supporting foundational growth in pioneering tech ventures.
The firm targets technology companies exhibiting strong potential for industry impact. BlackMars Capital's vision aims to redefine sectors through cultivating sustainable businesses, generating value for shareholders. It also strives to create engaging career opportunities, positioning itself as a significant enabler of future technological advancement.
BlackMars Capital has 3 tracked investments across 2 companies. The latest tracked deal is $100.0M Series C in Odyssey Therapeutics in December 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 1, 2023 | Odyssey Therapeutics | $100.0M Series C | Lorence KIM | OrbiMed, SR ONE, Third Rock Ventures, AB Magnitude Ventures Group, Alexandria Venture Investments, Catalio Capital, Colt Ventures, Creacion Ventures, CU Healthcare Innovation Fund, Fidelity Management & Research Company, Foresite Capital, General Catalyst, Global Bioaccess Fund, HBM Healthcare Investments, KB Investment, Racing Beach Ventures, T. Rowe Price Associates, Walleye Capital, Woodline Partners |
| Jul 18, 2023 | Circus Group | $6.2M Other Equity | 2BX, Blackmars Capital | — |
| Nov 1, 2022 | Circus Group | $11.0M Seed | 2BX, Blackmars Capital | Outrun Ventures, LEA Sophie Cramer, Mario Götze, Verena Pausder |
